GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (CHIX:GALDz) » Definitions » Accumulated Depreciation

Galderma Group AG (CHIX:GALDZ) Accumulated Depreciation : CHF-221 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Galderma Group AG's quarterly accumulated depreciation stayed the same from . 20 (CHF0 Mil) to Jun. 2023 (CHF0 Mil) but then increased from Jun. 2023 (CHF0 Mil) to Jun. 2024 (CHF-221 Mil).


Galderma Group AG Accumulated Depreciation Historical Data

The historical data trend for Galderma Group AG's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Accumulated Depreciation Chart

Galderma Group AG Annual Data
Trend
Accumulated Depreciation

Galderma Group AG Semi-Annual Data
Jun23 Jun24
Accumulated Depreciation - -220.77

Galderma Group AG Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.


Galderma Group AG Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.


Galderma Group AG Business Description

Traded in Other Exchanges
Address
Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines